B
18.00
-0.17 (-0.94%)
| Penutupan Terdahulu | 18.17 |
| Buka | 18.17 |
| Jumlah Dagangan | 503,756 |
| Purata Dagangan (3B) | 403,170 |
| Modal Pasaran | 983,024,576 |
| Harga / Buku (P/B) | 2.52 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Nov 2025 |
| EPS Cair (TTM) | -1.69 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.13% |
| Nisbah Semasa (MRQ) | 24.62 |
| Aliran Tunai Operasi (OCF TTM) | -88.27 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -53.72 M |
| Pulangan Atas Aset (ROA TTM) | -13.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Bicara Therapeutics Inc. | Menurun | Menurun |
AISkor Stockmoo
-0.6
| Konsensus Penganalisis | -3.5 |
| Aktiviti Orang Dalam | -2.5 |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | -0.60 |
|
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 11.65% |
| % Dimiliki oleh Institusi | 89.28% |
| Julat 52 Minggu | ||
| Median | 11.00 (-38.89%) | |
| Jumlah | 1 Pegang | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wells Fargo | 11 Nov 2025 | 11.00 (-38.89%) | Pegang | 14.73 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| HYEP IVAN | - | 18.88 | -17,795 | -335,970 |
| MAZUMDAR CLAIRE | - | 18.88 | -41,163 | -777,157 |
| RABEN DAVID | - | 18.67 | -11,000 | -205,370 |
| Jumlah Keseluruhan Kuantiti Bersih | -69,958 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,318,497 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 18.78 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| RABEN DAVID | Pegawai | 25 Nov 2025 | Jual automatik (-) | 5,500 | 18.46 | 101,530 |
| RABEN DAVID | Pegawai | 25 Nov 2025 | Pelaksanaan pilihan | 5,500 | - | - |
| RABEN DAVID | Pegawai | 24 Nov 2025 | Jual automatik (-) | 5,500 | 18.88 | 103,840 |
| RABEN DAVID | Pegawai | 24 Nov 2025 | Pelaksanaan pilihan | 5,500 | - | - |
| MAZUMDAR CLAIRE | Pegawai | 24 Nov 2025 | Jual automatik (-) | 41,163 | 18.88 | 777,157 |
| MAZUMDAR CLAIRE | Pegawai | 24 Nov 2025 | Pelaksanaan pilihan | 41,163 | - | - |
| HYEP IVAN | Pegawai | 24 Nov 2025 | Jual automatik (-) | 17,795 | 18.88 | 335,970 |
| HYEP IVAN | Pegawai | 24 Nov 2025 | Pelaksanaan pilihan | 17,795 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |